Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies. | Adv Drug Deliv Rev | 2021 | 34715258 | PubTator, text mining | PubMed |
| Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis. | Front Pharmacol | 2021 | 34712131 | PubTator, text mining | PubMed |
| GD2 CAR T cells against human glioblastoma. | NPJ Precis Oncol | 2021 | 34707200 | PubTator, text mining | PubMed |
| CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report. | Front Immunol | 2021 | 34691036 | PubTator, text mining | PubMed |
| What Do We Know about Pruritus in Very Young Infants? A Literature Review. | Cells | 2021 | 34685768 | PubTator, text mining | PubMed |
| Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research. | Pharmaceutics | 2021 | 34683830 | PubTator, text mining | PubMed |
| Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors. | Biomedicines | 2021 | 34680614 | PubTator, text mining | PubMed |
| A Multi-mRNA Prognostic Signature for Anti-TNFα Therapy Response in Patients with Inflammatory Bowel Disease. | Diagnostics (Basel) | 2021 | 34679598 | PubTator, text mining | PubMed |
| In Vitro Models Mimicking Immune Response in the Skin. | Yonsei Med J | 2021 | 34672130 | PubTator, text mining | PubMed |
| Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target. | Front Immunol | 2021 | 34671341 | PubTator, text mining | PubMed |
| IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation. | Cancer Biol Med | 2021 | 34652890 | PubTator, text mining | PubMed |
| Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network. | Front Med (Lausanne) | 2021 | 34650991 | PubTator, text mining | PubMed |
| Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects. | Int J Mol Sci | 2021 | 34638961 | PubTator, text mining | PubMed |
| Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy. | Cancers (Basel) | 2021 | 34638471 | PubTator, text mining | PubMed |
| Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study. | Ther Adv Respir Dis | 2021 | 34629000 | PubTator, text mining | PubMed |
| caAtlas: An immunopeptidome atlas of human cancer. | iScience | 2021 | 34622160 | PubTator, text mining | PubMed |
| Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD. | Blood Adv | 2021 | 34619767 | PubTator, text mining | PubMed |
| Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma. | Sci Adv | 2021 | 34613775 | PubTator, text mining | PubMed |
| Pharmacological strategies for improving the prognosis of glioblastoma. | Expert Opin Pharmacother | 2021 | 34605345 | PubTator, text mining | PubMed |
| Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis. | Medicine (Baltimore) | 2021 | 34596112 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=51